SHORT-TERM CHANGES OF SERUM POTASSIUM CONCENTRATION INDUCED BY PHYSICAL EXERCISE IN PATIENTS WITH ARTERIAL HYPERTENSION TREATED WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITOR ALONE OR IN COMBINATION WITH STATIN

被引:0
|
作者
Deska, P. [1 ]
Nowicki, M. [2 ]
机构
[1] Dept Internal Med Dist Hosp, Klobuck, Poland
[2] Med Univ Lodz, Dept Nephrol Hypertens & Kidney Transplantat, 251 Pomorska St, PL-92213 Lodz, Poland
来源
关键词
hyperkalemia; physical exercise; arterial hypertension; angiotensin-converting enzyme inhibitor; hydroxy-methyl-glutaryl-coenzyme A; reductase inhibitor; RHABDOMYOLYSIS; HYPERKALEMIA; MANAGEMENT; HYDRATION; WINGATE; TIME;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Intensive physical exercise may facilitate potassium release from skeletal muscles that may result in hyperkalemia. Commonly used drugs including angiotensin converting enzyme inhibitors (ACEI) and statins increase a risk of hyperkalemia. It is not known whether the effect of these drugs on serum potassium during physical exercise is additive. The study compared the effect of physical exercise on the changes of serum potassium in hypertensive patients receiving ACEI alone or in combination with statin. Eighteen patients with arterial hypertension with normal renal function were included in a prospective placebo-controlled cross-over study. The patients underwent 3 exercise tests on a bicycle ergometer with 55 - 60% of maximum oxygen consumption each lasting 30 minutes, i.e. after being treated with ACEI alone for six months, and then in a random order after the administration of ACEI with statin or ACEI with placebo each time for eight weeks separated by 2-week wash-out. Serum potassium was measured with atomic emission flame spectrometry before and after 15 and 30 minutes exercise and after 30-minute recovery. During the exercise serum potassium concentration increased moderately but significantly during all exercise tests. Mean serum potassium during exercise remained within the normal range. There were no differences in the exercise-induced changes of serum potassium during the exercise tests performed after ACEI combined with statin or with placebo. Addition of statin to ACEI does not increase the risk of hyperkalemia in hypertensive patients with preserved renal function during physical exercise with intensity typical for routine daily activities.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 50 条
  • [31] Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure
    Kinugawa, T
    Kato, M
    Mori, M
    Endo, A
    Kato, T
    Hamada, T
    Noguchi, N
    Omodani, H
    Osaki, S
    Ogino, K
    Miyakoda, H
    Hisatome, I
    Shigemasa, C
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) : 209 - 214
  • [32] CHANGES APELIN BLOOD LEVELS DEPENDING ON TREATMENT WITH ANGIOTENSIN II RECEPTOR BLOCKER OR ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN HYPERTENSION PATIENTS WITH TYPE 2 DIABETES
    Iushko, K.
    Koval, S.
    Starchenko, T.
    JOURNAL OF HYPERTENSION, 2017, 35 : E279 - E279
  • [33] A retrospective electronic chart review of blood pressure changes in elderly patients treated with amlodipine or an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker
    Dollar, A
    Brown, C
    Putnam, D
    McLaughlin, T
    Okamoto, L
    Arocho, R
    CLINICAL THERAPEUTICS, 2002, 24 (06) : 930 - 941
  • [34] Dual angiotensin-II suppression with angiotensin-converting enzyme inhibitor and irbesartan improves submaximal exercise time without changes in exercise-induced neurohumoral response in patients with congestive heart failure
    Blanchet, M
    Sheppard, R
    Curnier, D
    de Champlain, J
    Sirois, P
    Créo, H
    Roof, A
    Whittom, L
    Tardif, JC
    Ducharme, A
    Racine, N
    White, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 159A - 159A
  • [35] Short-term effects of angiotensin receptor blockers on blood pressure control, and plasma inflammatory and fibrinolytic parameters in patients taking angiotensin-converting enzyme inhibitors
    Agirbasli, Mehmet
    Cincin, Altug
    Baykan, Oytun A.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2008, 9 (01) : 22 - 26
  • [36] Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: A placebo-controlled, randomized study
    Dalsgaard, Morten
    Iversen, Kasper
    Kjaergaard, Jesper
    Grande, Peer
    Goetze, Jens Peter
    Clemmensen, Peter
    Hassager, Christian
    AMERICAN HEART JOURNAL, 2014, 167 (02) : 226 - 234
  • [37] FOSENOPRIL, AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, AND PROPRANOLOL - COMPARATIVE EFFECTS AT REST AND EXERCISE ON BLOOD-PRESSURE, HORMONAL VARIABLES, AND PLASMA POTASSIUM IN ESSENTIAL-HYPERTENSION
    SULLIVAN, PA
    CERVENKA, J
    OCONNOR, DT
    DINEEN, M
    CARDIOVASCULAR DRUGS AND THERAPY, 1989, 3 (01) : 57 - 62
  • [38] Effects of angiotensin-converting enzyme inhibitor and α1- adrenoceptor antagonist on hypertension induced in rats by long- term inhibition of nitric oxide production
    Takahashi M.
    Otsuka F.
    Ogura T.
    Yamauchi T.
    Kataoka H.
    Kishida M.
    Mimura Y.
    Makino H.
    Clinical and Experimental Nephrology, 2000, 4 (2) : 126 - 132
  • [39] Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats
    Kanno, S
    Wu, YJL
    Lee, PC
    Billiar, TR
    Ho, C
    CIRCULATION, 2001, 104 (08) : 945 - 950
  • [40] Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients
    Vaur, L
    Bobrie, G
    Dutrey-Dupagne, C
    Dubroca, I
    Vaisse, B
    d'Yvoire, MB
    Elkik, F
    Chatellier, G
    Menard, J
    AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (02) : 165 - 173